bupropion has been researched along with moclobemide in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Assalian, P; Margolese, HC | 1 |
Adams, DP; Covey, LS; Glassman, AH; Johnston, JA; Robinson, MD; Sullivan, MA | 1 |
Bagby, RM; Kennedy, SH; Vanderkooy, JD | 1 |
Croft, HA; Labbate, LA; Oleshansky, MA | 1 |
Nikiforuk, A; Wesołowska, A | 1 |
Choong, E; Eap, CB; Guillarme, D; Haldemann, S; Kottelat, A; Rudaz, S; Veuthey, JL | 1 |
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N | 1 |
Pieróg, M; Poleszak, E; Serefko, A; Szopa, A; Wlaź, A; Wlaź, P; Wośko, S; Wróbel, A; Wyska, E | 1 |
Doboszewska, U; Poleszak, E; Serefko, A; Świąder, K; Szopa, A; Szponar, J; Sławińska, K; Wlaź, A; Wlaź, P; Wośko, S; Wróbel, A; Wyska, E | 1 |
3 review(s) available for bupropion and moclobemide
Article | Year |
---|---|
Sexual side effects of antidepressants: a review.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Bupropion; Female; Humans; Libido; Male; Moclobemide; Monoamine Oxidase Inhibitors; Penile Erection; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunctions, Psychological | 1996 |
Advances in non-nicotine pharmacotherapy for smoking cessation.
Topics: Antidepressive Agents; Bupropion; Buspirone; Clonidine; Humans; Moclobemide; Narcotic Antagonists; Smoking Cessation | 2000 |
Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation.
Topics: Antidepressive Agents; Bupropion; Controlled Clinical Trials as Topic; Depressive Disorder; Doxepin; Drug Tolerance; Erectile Dysfunction; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Orgasm; Piperazines; Remission, Spontaneous; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triazoles | 2003 |
9 other study(ies) available for bupropion and moclobemide
Article | Year |
---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Practical approaches to the treatment of social phobia.
Topics: Adrenergic beta-Antagonists; Behavior Therapy; Benzamides; Benzodiazepines; Bupropion; Clonazepam; Comorbidity; Female; Fluoxetine; Humans; Male; Mental Disorders; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Prevalence | 1994 |
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Bupropion; Canada; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Drug Synergism; Imipramine; Injections, Intraperitoneal; Male; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulfonamides | 2008 |
Quantification of 4 antidepressants and a metabolite by LC-MS for therapeutic drug monitoring.
Topics: Antidepressive Agents; Bupropion; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Humans; Moclobemide; Morpholines; Reboxetine; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Trazodone | 2011 |
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Bupropion; Caffeine; Cyclohexanols; Cyclopropanes; Drug Evaluation, Preclinical; Drug Interactions; Male; Mice; Milnacipran; Moclobemide; Motor Activity; Swimming; Venlafaxine Hydrochloride | 2015 |
Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Bupropion; Cannabinoid Receptor Modulators; Endocannabinoids; Male; Mice; Moclobemide; Tissue Distribution | 2020 |